Opportunity ID: 335112

General Information

Document Type: Grants Notice
Funding Opportunity Number: RFA-CA-21-053
Funding Opportunity Title: Coordinating and Data Management Center for Acquired Resistance to Therapy Network (ARTNet; U24 Clinical Trial Not Allowed)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Education
Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.353 — 21st Century Cures Act – Beau Biden Cancer Moonshot
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Aug 04, 2021
Last Updated Date: Aug 04, 2021
Original Closing Date for Applications: Nov 01, 2021
Current Closing Date for Applications: Nov 01, 2021
Archive Date: Dec 07, 2021
Estimated Total Program Funding:
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: Public housing authorities/Indian housing authorities
Native American tribal governments (Federally recognized)
Special district governments
Public and State controlled institutions of higher education
County governments
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Native American tribal organizations (other than Federally recognized tribal governments)
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Independent school districts
For profit organizations other than small businesses
City or township governments
Private institutions of higher education
Small businesses
State governments
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.

Additional Information

Agency Name: National Institutes of Health
Description: Through this Funding Opportunity Announcement (FOA), the National Cancer Institute (NCI) invites applications from appropriate multidisciplinary groups to support a Coordinating Center to facilitate overall coordination across the Acquired Resistance to Therapy Network (ARTNet; see U54 awards supported under companion RFA-CA-21-052). The overarching goal of the ARTNet is to bridge basic, pre-clinical, and translational research along the tumor-tumor microenvironment continuum to inform new strategies that can be better translated to overcome significant challenges in acquired resistance to cancer therapies. The Coordinating Center will assemble the appropriate infrastructure to facilitate and implement the administrative, outreach, collaborative, and data management activities of the ARTNet.
Link to Additional Information: http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-21-053.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster
OERWebmaster03@od.nih.gov
Email:OERWebmaster03@od.nih.gov

Version History

Version Modification Description Updated Date

Related Documents

Packages

Agency Contact Information: NIH OER Webmaster
OERWebmaster03@od.nih.gov
Email: OERWebmaster03@od.nih.gov
Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
FORMS-F Use for due dates on or before January 24, 2022 PKG00268423 Oct 01, 2021 Jan 24, 2022 View
FORMS-G Use for due dates on or after January 25, 2022 PKG00269608 Oct 27, 2021 Nov 01, 2021 View

Package 1

Mandatory forms

335112 RR_SF424_2_0-2.0.pdf

335112 PHS398_CoverPageSupplement_5_0-5.0.pdf

335112 RR_OtherProjectInfo_1_4-1.4.pdf

335112 PerformanceSite_2_0-2.0.pdf

335112 RR_KeyPersonExpanded_2_0-2.0.pdf

335112 RR_Budget_1_4-1.4.pdf

335112 PHS398_ResearchPlan_4_0-4.0.pdf

335112 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf

Optional forms

335112 RR_SubawardBudget30_1_4-1.4.pdf

335112 PHS_AssignmentRequestForm_3_0-3.0.pdf

Package 2

Mandatory forms

335112 RR_SF424_5_0-5.0.pdf

335112 PHS398_CoverPageSupplement_5_0-5.0.pdf

335112 RR_OtherProjectInfo_1_4-1.4.pdf

335112 PerformanceSite_4_0-4.0.pdf

335112 RR_KeyPersonExpanded_4_0-4.0.pdf

335112 RR_Budget_3_0-3.0.pdf

335112 PHS398_ResearchPlan_4_0-4.0.pdf

335112 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf

Optional forms

335112 RR_SubawardBudget30_3_0-3.0.pdf

335112 PHS_AssignmentRequestForm_3_0-3.0.pdf

2025-07-11T16:28:36-05:00

Share This Post, Choose Your Platform!

About the Author: